✓ Credit card payment restored — secure checkout via Privacy Shield

Actorise

Actorise (Darbepoetin 25/40 mcg) — Emcure long-acting erythropoiesis-stimulating agent for CKD anaemia and chemotherapy-induced anaemia. FDA black-box for tumour progression.

Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience  · Last reviewed: May 2026

Encrypted checkout
Crypto pays 10% less
Discreet worldwide delivery
1,400+ customers · 50+ countries

This product is currently out of stock and unavailable.

Quick Answer

Actorise — Darbepoetin Alfa 25/40 mcg (Emcure Pharmaceuticals). Long-acting erythropoiesis-stimulating agent (ESA) for anaemia of chronic kidney disease and chemotherapy-induced anaemia. Subcutaneous or intravenous; longer half-life than epoetin alfa (3× weekly to 1× weekly dosing).

What you get with MedsBase:

  • WHO-GMP certified manufacturer
  • Discreet plain-envelope packaging
  • Worldwide shipping
  • Rated by 1,400+ customers (read reviews)

📦 Reshipment Assurance: if your order has not arrived 20 business days after dispatch, we reship it at no extra cost. Read the policy.

Why order from MedsBase

Actorise ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.

⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.

FDA black-box: increased mortality + tumour progression
Multiple FDA black-box warnings: increased risk of death, MI, stroke, VTE, and tumour progression in cancer patients. Use only when haemoglobin is <10 g/dL with symptoms. Aim for lowest dose to avoid transfusion — do NOT target Hb >11-12 g/dL. Use only when curative chemotherapy is NOT planned (associated with reduced survival in adjuvant settings).

Frequently Asked Questions

When is this used?

Long-acting erythropoiesis-stimulating agent (ESA) for anaemia of chronic kidney disease and chemotherapy-induced anaemia. Subcutaneous or intravenous; longer half-life than epoetin alfa (3× weekly to 1× weekly dosing).

Side effects?

Class-specific — see safety boxes above. Most supportive cancer medications are well-tolerated when used per protocol but require specialist supervision.

Drug interactions?

Always disclose all medications. Cancer supportive therapy interacts with multiple cytotoxics, chemo regimens, and concomitant medications.

Pregnancy?

Variable by molecule. Consult oncology for pregnancy planning during cancer therapy.

Monitoring?

Specialist-determined — typically FBC, electrolytes, renal/liver function, cardiac monitoring as relevant.

What if I miss a dose?

Take when you remember; do not double up. Discuss with oncology team if multiple doses missed.

When is treatment finished?

Determined by clinical response, planned regimen length, and patient tolerance.

Storage?

Per package insert — typically below 25-30°C, away from light and moisture. Pregnant household members should not handle broken tablets/capsules.

Cost?

Generic Indian biosimilars and chemical equivalents are dramatically less expensive than originator products with documented bioequivalence and clinical equivalence.

Vaccines?

Coordinate with oncology — live vaccines may be contraindicated during cancer therapy.

Other Cancer & Supportive Medications

  • Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
  • Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
  • Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
  • Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
  • Actorise — darbepoetin alfa — for chemotherapy-induced anaemia
Medical Disclaimer: Cancer therapy is highly individualised. Specific drug, dose, schedule, monitoring, and supportive care must be determined by a qualified oncologist or haematologist based on tumour biology, staging, comorbidities, and goals of care. This information is educational; it does not substitute for professional medical advice.

More options in Anti Cancer Medication

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Strength

25 mcg, 40 mcg

Quantity

1 Injection/s, 3 Injection/s, 6 Injection/s

Pharma Form

Injection/s

Manufacturer

Cipla Inc

Treatment

Anti Cancer

Generic Brand

Darbepoetin alfa

Reviews

There are no reviews yet

Add a review
Actorise Actorise
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review

Q & A

Ask a question
Actorise Actorise
Your question
* Question is required
Name
* Name is required
There are no questions yet